Literature DB >> 31950474

Soft Tissue Special Issue: Fibroblastic and Myofibroblastic Neoplasms of the Head and Neck.

Esther Baranov1, Jason L Hornick2.   

Abstract

Fibroblastic and myofibroblastic neoplasms of the head and neck encompass a group of rare tumor types with often overlapping clinicopathologic features that range in biologic potential from benign to overtly malignant. Even neoplasms with no metastatic potential may provide significant therapeutic challenges in this region due to the unique anatomy of the head and neck. This review will cover the following entities, highlighting important clinical aspects of each neoplasm and then focusing on their characteristic histomorphology, immunophenotype, and molecular alterations: nodular and cranial fasciitis, fibrous hamartoma of infancy, nasopharyngeal angiofibroma, nuchal-type and Gardner fibromas, desmoid fibromatosis, dermatofibrosarcoma protuberans and giant cell fibroblastoma, solitary fibrous tumor, inflammatory myofibroblastic tumor, low-grade myofibroblastic sarcoma, infantile fibrosarcoma, low-grade fibromyxoid sarcoma, and sclerosing epithelioid fibrosarcoma. While some of these neoplasms characteristically arise in the head and neck, others are rarely described in this anatomic region and may therefore be particularly difficult to recognize. Distinction between these entities, however, is crucial, particularly as the molecular pathogenetic basis for these neoplasms are being rapidly elucidated, in some instances allowing for targeted therapeutic approaches.

Entities:  

Keywords:  Beta-catenin; MUC4; NTRK; STAT6; Soft tissue tumors; Translocation

Mesh:

Year:  2020        PMID: 31950474      PMCID: PMC7021862          DOI: 10.1007/s12105-019-01104-3

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  132 in total

1.  Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor).

Authors:  S Tejpar; F Nollet; C Li; J S Wunder; G Michils; P dal Cin; E Van Cutsem; B Bapat; F van Roy; J J Cassiman; B A Alman
Journal:  Oncogene       Date:  1999-11-11       Impact factor: 9.867

Review 2.  Low-Grade Fibromyxoid Sarcoma of the Head and Neck: A Clinicopathologic Series and Review of the Literature.

Authors:  Morgan L Cowan; Lester D Thompson; Marino E Leon; Justin A Bishop
Journal:  Head Neck Pathol       Date:  2015-08-15

3.  Correlation between clinicopathological features and karyotype in spindle cell sarcomas. A report of 130 cases from the CHAMP study group.

Authors:  C D Fletcher; P Dal Cin; I de Wever; N Mandahl; F Mertens; F Mitelman; J Rosai; A Rydholm; R Sciot; G Tallini; H van den Berghe; R Vanni; H Willén
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

4.  MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma.

Authors:  Leona A Doyle; Emely Möller; Paola Dal Cin; Christopher D M Fletcher; Fredrik Mertens; Jason L Hornick
Journal:  Am J Surg Pathol       Date:  2011-05       Impact factor: 6.394

5.  Hormonal receptors and vascular endothelial growth factor in juvenile nasopharyngeal angiofibroma: immunohistochemical and tissue microarray analysis.

Authors:  Zhuofu Liu; Jingjing Wang; Huan Wang; Dehui Wang; Li Hu; Quan Liu; Xicai Sun
Journal:  Acta Otolaryngol       Date:  2014-11-11       Impact factor: 1.494

Review 6.  Cranial fasciitis of childhood: a case report.

Authors:  Y Kumon; S Sakaki; M Sakoh; K Nakano; K Fukui; K Kurihara
Journal:  Surg Neurol       Date:  1992-07

7.  Nodular fasciitis: an analysis of 250 patients.

Authors:  S Shimizu; H Hashimoto; M Enjoji
Journal:  Pathology       Date:  1984-04       Impact factor: 5.306

8.  Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases.

Authors:  Melissa H Cessna; Holly Zhou; Warren G Sanger; Sherrie L Perkins; Sheryl Tripp; Diane Pickering; Clark Daines; Cheryl M Coffin
Journal:  Mod Pathol       Date:  2002-09       Impact factor: 7.842

9.  Treatment-refractory ALK-positive inflammatory myofibroblastic tumour of the oral cavity.

Authors:  Anna W LaVigne; David M Meredith; David R D'Adamo; Danielle N Margalit
Journal:  BMJ Case Rep       Date:  2018-04-11

10.  Gardner Fibroma: Clinical and Histopathologic Implications of Germline APC Mutation Association.

Authors:  Nathan A Dahl; Amy Sheil; Sarah Knapke; James I Geller
Journal:  J Pediatr Hematol Oncol       Date:  2016-07       Impact factor: 1.289

View more
  5 in total

1.  Laryngeal Manifestation of Nodular Fasciitis: A Case Report and Literature Review.

Authors:  Rupert Stadlhofer; Andreas Lübke; Arne Böttcher
Journal:  Cureus       Date:  2021-11-23

2.  Molecular characterization of an embryonal rhabdomyosarcoma occurring in a patient with Kabuki syndrome: report and literature review in the light of tumor predisposition syndromes.

Authors:  Sietse M Aukema; Selina Glaser; Mari F C M van den Hout; Sonja Dahlum; Marinus J Blok; Morten Hillmer; Julia Kolarova; Raf Sciot; Dina A Schott; Reiner Siebert; Constance T R M Stumpel
Journal:  Fam Cancer       Date:  2022-07-19       Impact factor: 2.446

3.  Aggressive Intraosseous Myofibroma of the Maxilla: Report of a Rare Case and Literature Review.

Authors:  John Lennon Silva Cunha; Carla Isabelly Rodrigues-Fernandes; Ciro Dantas Soares; Celeste Sánchez-Romero; Pablo Agustin Vargas; Cleverson Luciano Trento; Bruno Augusto Benevenuto de Andrade; Sílvia Ferreira de Sousa; Ricardo Luiz Cavalcanti de Albuquerque-Júnior
Journal:  Head Neck Pathol       Date:  2020-04-25

4.  A rare case of maxillary nodular fasciitis: Case report and short literature review.

Authors:  Mauro Massarelli; Francesco Paparo; Simone Benedetti
Journal:  Clin Case Rep       Date:  2020-11-21

5.  Case Report: Radiological Features of Sclerosing Epithelioid Fibrosarcoma in the Right Fibula.

Authors:  Qiaoling Ding; Xiaotong Shao; Xiaocao Liu; Yanbiao Fu; Fengbo Huang; Chao Wang
Journal:  Front Oncol       Date:  2020-11-18       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.